Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $4,043,356 | $3,469,842 | $4,756,287 | $2,847,345 |
| - Cash | $74,400 | $120,900 | $118,400 | $227,400 |
| + Debt | $504,500 | $329,100 | $318,600 | $355,000 |
| Enterprise Value | $4,473,456 | $3,678,042 | $4,956,487 | $2,974,945 |
| Revenue | $761,500 | $681,800 | $608,000 | $515,100 |
| % Growth | 11.7% | 12.1% | 18% | – |
| Gross Profit | $426,300 | $384,800 | $345,900 | $291,600 |
| % Margin | 56% | 56.4% | 56.9% | 56.6% |
| EBITDA | $86,700 | $178,900 | $162,000 | $131,000 |
| % Margin | 11.4% | 26.2% | 26.6% | 25.4% |
| Net Income | -$27,900 | $58,200 | $55,500 | $33,900 |
| % Margin | -3.7% | 8.5% | 9.1% | 6.6% |
| EPS Diluted | -0.24 | 0.53 | 0.51 | 0.33 |
| % Growth | -145.3% | 3.9% | 54.5% | – |
| Operating Cash Flow | $63,600 | $122,900 | $123,087 | $106,400 |
| Capital Expenditures | -$30,300 | -$77,600 | -$186,219 | -$49,200 |
| Free Cash Flow | $33,300 | $45,300 | $96,978 | $57,200 |